Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Neoplasms 23Venous Thromboembolism 20Febrile Neutropenia 20Anemia 20Thrombocytopenia 15Myelodysplastic Syndromes 14Leukemia, Myeloid, Acute 14Lymphoma 12Leukemia 12Anemia, Refractory, with Excess of Blasts 10Anemia, Aplastic 10Colorectal Neoplasms 9Breast Neoplasms 8Anemia, Iron-Deficiency 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Anemia, Sickle Cell 7Neutropenia 6Multiple Myeloma 6Ovarian Neoplasms 5Neoplasms, Plasma Cell 5Lymphoma, Follicular 5Hematologic Neoplasms 5Fanconi Anemia, Complementation Group D1 5Hemophilia A 4Chemotherapy-induced Thrombocytopenia 4Stroke 3Pulmonary Disease, Chronic Obstructive 3Parkinson Disease 3Osteoporosis 3Multiple Sclerosis 3

Interventions

Thrombopoietin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Cancer Treatment Induced Thrombocytopenia × Classical hematology × Clear all
NCT05411705 2024-03-01

Circular

The First Affiliated Hospital of Dalian Medical University

Phase 4 Unknown
165 enrolled
Classical hematology

Cancer Treatment Induced Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡